Dr. Wigneswaran W. Paramanathan

Kenneth D. Gold, MD joined Northwell Health Physician Partners and the Northwell Health Cancer Institute as an attending physician of the Department of Medicine.Kenneth D. Gold, MD graduated magna cum laude from Amherst College. He earned his medical degree at Baylor College of Medicine in Houston, Texas, and then trained in Internal Medicine at George Washington University, where he also served as Chief Medical Resident. His fellowship in Hematology and Medical Oncology was completed at Columbia Presbyterian Medical Center. Dr. Gold is board-certified in Internal medicine, Hematology and medical Oncology.Previously Chief of Hematology and Medical Oncology at Good Samaritan Hospital, West Islip, and an attending physician at Southside Hospital, Dr. Gold has been a leader in Suffolk County in the diagnosis and treatment of cancer and blood diseases since 1983. He served for many years as the Chair of the Transfusion Committees at both Good Samaritan Hospital Medical Center and Southside Hospital. Dr. Gold is a member of the American Society of Clinical Oncology. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Inflammatory Breast Cancer.

Ancy George is a primary care provider, practicing in Internal Medicine in Uniondale, New York. Dr. George is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Liver Embolization.

Michelle Logozzo is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Logozzo is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.